P2Y12 receptor specific versus non-P2Y12 receptor specific platelet function testing for prediction of pharmacodynamic and clinical outcomes in patients on dual antiplatelet therapy

被引：0
|
作者：
Amann, M. [1 ]
Valina, C. [1 ]
Stratz, C. [1 ]
Boemicke, T. [1 ]
Kleiner, P. [1 ]
Trenk, D. [1 ]
Neumann, F. -J. [1 ]
Hochholzer, W. [1 ]
机构：
[1] Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol 2, Bad Krozingen, Germany
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5605
引用
收藏
页码：1163 / 1163
页数：1
相关论文
共 50 条
  • [11] Platelet P2Y12 receptor signaling in patients with diabetes mellitus: an in vitro pharmacodynamic study
    Ueno, M.
    Ferreiro, J. L.
    Dharmashankar, K.
    Capodanno, D.
    Alissa, R.
    Desai, B.
    Tomasello, S. D.
    Charlton, R. K.
    Bass, T. A.
    Angiolillo, D. J.
    EUROPEAN HEART JOURNAL, 2010, 31 : 173 - 174
  • [12] New Perspectives for Antiplatelet Therapy: The Evolution of P2Y12 Receptor Antagonists
    da Silva, Paula Nogueira
    Barbosa, Maria Leticia de Castro
    REVISTA VIRTUAL DE QUIMICA, 2021, 13 (04) : 999 - 1016
  • [13] Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls
    Winter, Max-Paul
    Kozinski, Marek
    Kubica, Jacek
    Aradi, Daniel
    Siller-Matula, Jolanta M.
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2015, 11 (04): : 259 - 280
  • [14] Assessment of Prasugrel Antiplatelet P2Y12 Receptor Therapy in a Clopidogrel Nonresponder
    Ha, Thanh
    Nathan, Sandeep
    Mikrut, Krzysztof
    Miller, Jonathan L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (03) : 509 - 510
  • [15] P2Y12 receptor constitutive activity as a new target for antiplatelet therapy
    Garcia, C.
    Ribes, A.
    Nauze, M.
    N'guyen, D.
    Martinez, L. O.
    Payrastre, B.
    Senard, J. M.
    Gales, C.
    Pons, V.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 29 - 29
  • [16] Dual Therapy (P2Y12
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2019, 8 (04) : 256 - 256
  • [17] Inhibition of the platelet P2Y12 receptor potentiates the antiplatelet effect of prostacyclin.
    Cattaneo, Marco
    Lecchi, Anna
    BLOOD, 2006, 108 (11) : 216A - 216A
  • [18] Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function
    Judge, Heather M.
    Buckland, Robert J.
    Sugidachi, Atsuhiro
    Jakubowski, Joseph A.
    Storey, Robert F.
    THROMBOSIS AND HAEMOSTASIS, 2010, 103 (06) : 1210 - 1217
  • [19] The influence of P2Y12 receptor deficiency on the platelet inhibitory activities of prasugrel in a mouse model:: Evidence for specific inhibition of P2Y12 receptors by prasugrel
    Hashimoto, Masami
    Sugidachi, Atsuhiro
    Isobe, Takashi
    Niitsu, Yoichi
    Ogawa, Taketoshi
    Jakubowski, Joseph A.
    Asai, Fumitoshi
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (07) : 1003 - 1009
  • [20] Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y12 receptor between selatogrel and oral P2Y12 antagonists
    Henrich, Andrea
    Claussen, Christian Hove
    Dingemanse, Jasper
    Krause, Andreas
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (07): : 735 - 747
12345